TOCA 511 & TOCA FC: PRE-CLINICAL PROOF OF CONCEPT IN MEDULLOBLASTOMA

被引：0
|
作者：
Richardson, Angela M. [1 ,2 ]
Collins, Sara A. [3 ]
Inagaki, Akihito [3 ]
Armstrong, L. [4 ]
Roussel, Martine [5 ]
Jolly, Douglas [6 ]
Robbins, David J. [7 ,8 ]
Ayad, Nagi [9 ]
Kasahara, Noriyuki [10 ,11 ]
机构：
[1] Univ Miami, Dept Neurol Surg, Miami, FL USA
[2] Jackson Hlth Syst, Neurosurg Program, Miami, FL USA
[3] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
[4] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[5] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA
[6] Tocagen Inc, San Diego, CA USA
[7] Univ Miami, Dept Surg, Miami, FL USA
[8] Univ Miami, Dept Biochem, Miami, FL USA
[9] Univ Miami, Miami, FL USA
[10] Univ Miami, Dept Cell Biol, Miami, FL USA
[11] Univ Miami, Dept Pathol, Miami, FL USA
来源：
NEURO-ONCOLOGY | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PDTM-19
引用
收藏
页码：193 / 193
页数：1
相关论文
共 50 条
  • [41] Photopheresis efficacy in the treatment of rheumatoid arthritis: a pre-clinical proof of concept
    Céline Coppard
    Francis Bonnefoy
    Dalil Hannani
    Françoise Gabert
    Olivier Manches
    Joel Plumas
    Sylvain Perruche
    Laurence Chaperot
    Journal of Translational Medicine, 17
  • [42] Long-Term Follow-Up Data from 126 Patients with Recurrent High Grade Glioma from Three Phase 1 Trials of Toca 511 and Toca FC: Update and Justification for a Phase 2/3 Trial
    Jolly, Doug J.
    Aghi, Manish
    Vogelbaum, Michael A.
    Kalkanis, Steven N.
    Bota, Daniela
    Chen, Clark C.
    Carter, Bob
    Elder, Brad
    Engh, Johnathan
    Goldlust, Samuel A.
    Kaptain, George J.
    Kesari, Santosh
    Landolfi, Joseph
    Liau, Linda M.
    Mikkelsen, Tom
    Piccioni, David
    Portnow, Jana
    Singer, Samuel
    Walbert, Tobias
    Gruber, Harry
    Ibanez, Carlos
    Mitchell, Leah
    Ostertag, Derek
    Shorr, Jolene S.
    Yang, Liqiang
    Das, Asha
    Cloughesy, Timothy F.
    MOLECULAR THERAPY, 2017, 25 (05) : 24 - 25
  • [43] LONG-TERM FOLLOW-UP DATA FROM 126 PATIENTS WITH RECURRENT HIGH GRADE GLIOMA FROM THREE PHASE 1 TRIALS OF TOCA 511 AND TOCA FC: UPDATE AND JUSTIFICATION FOR A PHASE 2/3 TRIAL
    Aghi, M.
    Vogelbaum, M. A.
    Kalkanis, S. N.
    Bota, D.
    Piccioni, D.
    Elder, B.
    Engh, J.
    Kaptain, G. J.
    Landolfi, J.
    Cloughesy, T. F.
    NEURO-ONCOLOGY, 2017, 19 : 19 - 19
  • [44] Long-term follow-up data from 123 patients with recurrent high grade glioma from three Phase 1 trials of Toca 511 and Toca FC: Update and justification for a Phase 2/3 trial
    Huang, Tiffany T.
    Aghi, Manish
    Vogelbaum, Michael
    Kalkanis, Steven
    Bota, Daniela
    Carter, Bob
    Chen, Clark
    Elder, Bradley
    Kaptain, George
    Kesari, Santosh
    Cloughesy, Timothy
    Walbert, Tobias
    JOURNAL OF NEUROSURGERY, 2017, 126 (04) : A1414 - A1414
  • [45] Cardiac Hemodynamic Monitoring in the Subcutaneous Space A pre-clinical proof-of-concept
    Alvarez, Rafael Cordero
    Joubert, Pierre-Yves
    Ziglio, Filippo
    Amblard, Amel
    Feuerstein, Delphine
    2018 IEEE INTERNATIONAL SYMPOSIUM ON MEDICAL MEASUREMENTS AND APPLICATIONS (MEMEA), 2018, : 18 - 23
  • [46] Toca 511/5-FC Treatment Has the Potential to Increase the Therapeutic Efficacy of Anti-PD-1 Antibody in an Immunocompetent Murine Pancreatic Cancer Model
    Niwa, Hiroki
    Nakamura, Toru
    Kushiya, Hiroki
    Suzuki, Tomohiro
    Inoko, Kazuho
    Hiraoka, Kei
    Inagaki, Akihito
    Tsuchikawa, Takahiro
    Shichinohe, Toshiaki
    Noriyuki, Kasahara
    Hirano, Satoshi
    MOLECULAR THERAPY, 2023, 31 (04) : 298 - 298
  • [47] Topical upadacitinib is effective in distal ulcerative colitis: A case study and pre-clinical proof of concept
    Giri, Rabina
    Amiss, Anna
    Riches, Bruce
    De Jesus, Matheus Carpinelli
    Begun, Jakob
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 153 - 154
  • [48] Editorial: Understanding the concept of pre-clinical autoimmunity
    Olsen, Nancy J.
    Okuda, Darin T.
    Holers, V. Michael
    Karp, David R.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [49] Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression (vol 20, pg 1689, 2012)
    Perez, Omar D.
    Logg, Christopher R.
    Hiraoka, Kei
    Diago, Oscar
    Burnett, Ryan
    Inagaki, Akihito
    Jolson, Dawn
    Amundson, Karin
    Buckley, Taylor
    Lohse, Dan
    Lin, Amy
    Burrascano, Cindy
    Ibanez, Carlos
    Kasahara, Noriyuki
    Gruber, Harry E.
    Jolly, Douglas J.
    MOLECULAR THERAPY, 2013, 21 (02) : 494 - 494
  • [50] Gene therapy for infantile malignant osteopetrosis: review of pre-clinical research and proof-of-concept for phenotypic reversal
    Moscatelli, Ilana
    Almarza, Elena
    Schambach, Axel
    Ricks, David
    Schulz, Ansgar
    Herzog, Christopher D.
    Henriksen, Kim
    Askmyr, Maria
    Schwartz, Jonathan D.
    Richter, Johan
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 20 : 389 - 397
12345